Malignant transformation initiated by MII-AF9: Gene dosage and critical target cells

被引:166
作者
Chen, Weili [4 ]
Kumar, Ashish R. [1 ,4 ]
Hudson, Wendy A. [4 ]
Li, Quanzhi [4 ]
Wu, Baolin [3 ]
Staggs, Rodney A. [4 ]
Lund, Erik A. [4 ]
Sam, Thien N. [4 ]
Kersey, John H. [1 ,2 ,4 ]
机构
[1] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
关键词
CELLCYCLE;
D O I
10.1016/j.ccr.2008.03.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The pathways by which oncogenes, such as MLL-AF9, initiate transformation and leukemia in humans and mice are incompletely defined. In a study of target cells and oncogene dosage, we found that MII-AF9, when under endogenous regulatory control, efficiently transformed LSK (Lin(-)Scal(+)c-kit(+)) stem cells, while committed granulocyte-monocyte progenitors (GMPs) were transformation resistant and did not cause leukemia. MII-AF9 was expressed at higher levels in hematopoietic stem (HSC) than GMP cells. MII-AF9 gene dosage effects were directly shown in experiments where GMPs were efficiently transformed by the high dosage of MII-AF9 resulting from retroviral transduction. MII-AF9 upregulated expression of 192 genes in both LSK and progenitor cells, but to higher levels in LSKs than in committed myeloid progenitors.
引用
收藏
页码:432 / 440
页数:9
相关论文
共 31 条
[1]   A clonogenic common myeloid progenitor that gives rise to all myeloid lineages [J].
Akashi, K ;
Traver, D ;
Miyamoto, T ;
Weissman, IL .
NATURE, 2000, 404 (6774) :193-197
[2]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[3]   Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein [J].
Caslini, C ;
Serna, A ;
Rossi, V ;
Introna, M ;
Biondi, A .
LEUKEMIA, 2004, 18 (06) :1064-1071
[4]   Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia [J].
Chapiro, Elise ;
Russell, Lisa ;
Radford-Weiss, Isabelle ;
Bastard, Christian ;
Lessard, Michel ;
Struski, Stephanie ;
Cave, Helene ;
Fert-Ferrer, Sandra ;
Barin, Carole ;
Maarek, Odile ;
Della-Valle, Veronique ;
Strefford, Jonathan C. ;
Berger, Roland ;
Harrison, Christine J. ;
Bernard, Olivier A. ;
Nguyen-Khac, Florence .
BLOOD, 2006, 108 (10) :3560-3563
[5]   A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy [J].
Chen, Weili ;
Li, Quanzhi ;
Hudson, Wendy A. ;
Kumar, Ashish ;
Kirchhof, Nicole ;
Kersey, John H. .
BLOOD, 2006, 108 (02) :669-677
[6]   An MII-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes [J].
Corral, J ;
Lavenir, I ;
Impey, H ;
Warren, AJ ;
Forster, A ;
Larson, TA ;
Bell, S ;
McKenzie, ANJ ;
King, G ;
Rabbitts, TH .
CELL, 1996, 85 (06) :853-861
[7]   Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors [J].
Cozzio, A ;
Passegué, E ;
Ayton, PM ;
Karsunky, H ;
Cleary, ML ;
Weissman, IL .
GENES & DEVELOPMENT, 2003, 17 (24) :3029-3035
[8]   The MII-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis [J].
Dobson, CL ;
Warren, AJ ;
Pannell, R ;
Forster, A ;
Lavenir, I ;
Corral, J ;
Smith, AJH ;
Rabbitts, TH .
EMBO JOURNAL, 1999, 18 (13) :3564-3574
[9]   Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells [J].
Du, Y ;
Jenkins, NA ;
Copeland, NG .
BLOOD, 2005, 106 (12) :3932-3939
[10]   Global and Hox-specific roles for the MLL1 methyltransferase [J].
Guenther, MG ;
Jenner, RG ;
Chevalier, B ;
Nakamura, T ;
Croce, CM ;
Canaani, E ;
Young, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (24) :8603-8608